Radboudumc
RIMLS and RIHSThe Radboud Institute for Molecular Life Sciences (
RIMLS) and the RadboudInstitute of Health Sciences (
RIHS) in the Netherlands are leading European research schools providing an outstanding research and educational setting at the RadboudUMC. Together the RIMLS and RIHS focus on basic science and its translation into pioneering treatments for disease to the clinic.
Radiotherapy & OncoImmunology lab (Dept. of Radiation Oncology)In the newly established ROI lab, ~ 25 researchers aim at better understanding tumor cell interactions with the immune system using imaging, molecular-, cell biological- and immunological- techniques in relation to cancer therapies, especially radiotherapy. Research is centred around the development of in situ cancer vaccines combining local tumor ablation and dendritic cell (DC) activation through immune adjuvants. In addition, the interplay between immune- and tumor cells is studied within the tumor microenvironment (TME) and modulation of the TME on the efficacy of treatment. An important activity of the department is the translation of basic research into clinical application.
RadboudumcRadboudumc strives to be a leading developer of sustainable, innovative and affordable healthcare to improve the health and wellbeing of people and society in the Netherlands and beyond. This is the core of our mission: To have a significant impact on healthcare. To get a better picture of what this entails, check out our
strategy.
Read more about what it means
to work at Radboudumc and how you can do your part.